Skip to main content
. 2019 Apr 24;42(1):40–45. doi: 10.1016/j.htct.2019.01.010

Table 3.

Mortality.

Donor
p
HAPLO (n = 13) SIB (n = 10)
Mortality not related to relapse
 Myeloablative conditioning 3 2 0.8
 Reduced intensity conditioning 2 1 0.7



Relapse
 Myeloablative conditioning 5 3 0.9
 Reduced intensity conditioning 3 3 0.9
 Graft-versus-host disease 0 0
 Other causes after 2 years of ALOTH 0 1 n.s.